EULAR® 2024 Insights: Drug Survival of First-line TNF and Apremilast and Description of Second-line Therapy among PsA Patients in the CorEvitas PsA/SpA Registry

80 views
June 18, 2024
Comments 0
Login to view comments. Click here to Login